12:00 AM
Apr 28, 2014
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Shionogi, Viiv Healthcare sales and marketing update

ViiV and Shionogi launched ViiV's Tivicay dolutegravir in Japan to treat HIV infection in combination with other HIV drugs in patients ages 12 years and older. Japan's Ministry of Health, Labor and Welfare (MHLW)...

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >